Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $9.84, but opened at $10.14. Evolus shares last traded at $9.93, with a volume of 11,070 shares trading hands. Evolus Stock Up 0.8 % The firm’s fifty day moving average is $8.83 and […]
Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Needham & Company LLC in a report issued on Wednesday, Benzinga reports. They currently have a $22.00 price target on the stock. Needham & Company LLC’s target price suggests a potential upside of 122.90% from the stock’s current price. […]
This month’s International Trade Commission wrap-up focuses on the circumstances in which a complainant can amend its complaint. In particular, on November 2, 2023, Administrative Law.
Global Aesthetic Medicine Market Poised For Significant Growth, Anticipated To Reach $91 27 Billion By 2027 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The "Neurotoxin Market Forecast to 2028 - Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.